From the Globe and Mail:
Heart failure patients at the greatest risk of death are the least likely to be prescribed drugs that could prolong their lives, according to new Canadian research.
Scientists are at a loss to explain this paradox, particularly since there is ample evidence that the sickest patients benefit most from the host of drugs that are the mainstay of treatment.
"The million-dollar question is: 'Why is this happening?' " Douglas Lee, a research fellow at the Toronto-based Institute for Clinical Evaluative Sciences, said in an interview. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment